DEXAMETHASONE STIMULATES TRANSCRIPTION OF THE INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 GENE IN H4-II-E RAT HEPATOMA-CELLS

被引:75
作者
ORLOWSKI, CC [1 ]
OOI, GT [1 ]
RECHLER, MM [1 ]
机构
[1] NIDDKD,MOLEC CELLULAR & NUTR ENDOCRINOL BRANCH,GROWTH & DEV SECT,BETHESDA,MD 20892
关键词
D O I
10.1210/mend-4-10-1592
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Binding proteins for the insulin-like growth factors (IGFBP) are important modulators of the biological actions of IGF-I and IGF-II. Concentrations of one of these proteins, IGFBP-1, in human plasma and IGFBP-1 mRNA in rat liver are markedly altered in diabetes and fasting. We now examine the regulation of IGFBP-1 and IGFBP-I mRNA in H4-II-E cells, a rat cell line derived from the minimal deviation H35 Reuber hepatoma previously reported to synthesize IGFBP-1 as its predominant IGF-binding protein. Confluent H4-II-E cells in serum-free medium were incubated with different hormones for 48 h, and the conditioned medium was analyzed by ligand blotting. Dexamethasone (10-6 m) increased levels of 30-kDa IGFBP-1 approximately 10-fold; stimulation was half-maximal at 6 x 10-9 m dexamethasone. No stimulation was seen with progesterone, testosterone, IGF-I, or rat GH, whereas insulin gave a small inhibition. Immunoblot analysis using a monoclonal antibody to human IGFBP-1 confirmed that the 30-kDa IGFBP induced by dexamethasone was IGFBP-1. IGFBP-1 mRNA was increased to a similar extent (7-fold), as determined by Northern blot hybridization using human or rat IGFBP-1 cDNA probes. The stimulation of IGFBP-1 mRNA was observed within 3 h after the addition of dexamethasone; IGFBP-1 in the medium increased more slowly. After withdrawal of dexamethasone from stimulated cells, IGFBP-1 mRNA decreased by 80% after 48 h; IGFBP-1 decreased more slowly. The increased abundance of IGFBP-1 mRNA in dexamethasone-treated cells primarily reflected increased transcription rather than increased mRNA stability. The half-life of IGFBP-1 mRNA in unstimulated cells was 1.7 h and increased 50% in dexamethasone-treated cells. This increase is too small to account for the 10-fold increase in steady state levels of IGFBP-1 mRNA. The H4-II-E cell line provides a useful model system to define the molecular mechanisms of IGFBP-1 gene regulation and the biological role of IGFBP-I. © 1990 by The Endocrine Society.
引用
收藏
页码:1592 / 1599
页数:8
相关论文
共 53 条
[1]   TRANSCAPILLARY PERMEABILITY AND SUBENDOTHELIAL DISTRIBUTION OF ENDOTHELIAL AND AMNIOTIC-FLUID INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS IN THE RAT-HEART [J].
BAR, RS ;
CLEMMONS, DR ;
BOES, M ;
BUSBY, WH ;
BOOTH, BA ;
DAKE, BL ;
SANDRA, A .
ENDOCRINOLOGY, 1990, 127 (03) :1078-1086
[2]   SELECTION OF A DEXAMETHASONE-RESISTANT H-4-IIE-C3 RAT HEPATOMA TISSUE-CULTURE LINE [J].
BARNETT, CA ;
BARNHORST, M ;
FOOSHEE, CM ;
SANETO, RP .
IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION, 1979, 15 (02) :128-137
[3]   RADIOIMMUNOASSAY OF GROWTH-HORMONE DEPENDENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN HUMAN-PLASMA [J].
BAXTER, RC ;
MARTIN, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06) :1504-1512
[4]   DIURNAL RHYTHM OF GROWTH HORMONE-INDEPENDENT BINDING-PROTEIN FOR INSULIN-LIKE GROWTH-FACTORS IN HUMAN-PLASMA [J].
BAXTER, RC ;
COWELL, CT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :432-440
[5]   REGULATION OF HEPATIC EXPRESSION OF IGF-I AND FETAL IGF BINDING-PROTEIN MESSENGER-RNA IN STREPTOZOTOCIN-DIABETIC RATS [J].
BONISCHNETZLER, M ;
BINZ, K ;
MARY, JL ;
SCHMID, C ;
SCHWANDER, J ;
FROESCH, ER .
FEBS LETTERS, 1989, 251 (1-2) :253-256
[6]   INSULIN REGULATES THE 35-KDA IGF BINDING-PROTEIN IN PATIENTS WITH DIABETES-MELLITUS [J].
BRISMAR, K ;
GUTNIAK, M ;
POVOA, G ;
WERNER, S ;
HALL, K .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1988, 11 (08) :599-602
[7]  
BROWN AL, 1986, J BIOL CHEM, V261, P3144
[8]  
BUSBY WH, 1988, J BIOL CHEM, V263, P14203
[9]   RADIOIMMUNOASSAY OF A 26,000-DALTON PLASMA INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN - CONTROL BY NUTRITIONAL VARIABLES [J].
BUSBY, WH ;
SNYDER, DK ;
CLEMMONS, DR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (06) :1225-1230
[10]  
COEZY E, 1984, IN VITRO CELL DEV B, V20, P528